Natalia Lopez-Vilanova

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
PURPOSE To verify a Tomotherapy plan for a typical head and neck treatment against experimental measurements. METHODS The treatment plan for a head and neck case was generated by the Tomotherapy treatment planning system (TPS) to deliver ∼70 Gy in 33 sessions to the contoured PTV. The plan was calculated on a CIRS ATOM anthropomorphic phantom that(More)
Introduction: [11C]GSK931145 is a novel PET radiotracer for the glycine transporter type 1 (GlyT1), with promising characteristics in preclinical species (1). A human test–retest study in 10 healthy human volunteers produced poor test–retest statistics, with mean coefficient of variation (COV) of volume of distribution (VT; 2 tissue compartmental model)(More)
Human dosimetry studies play a central role in radioligand development for positron emission tomography (PET). Drawing regions of interest (ROIs) on the PET images is used to measure the dose in each organ. In the study aspects related to ROI delineation methods were evaluated for two radioligands of different biodistribution (intestinal vs urinary). PET(More)
  • 1